Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.82USD
15 Dec 2017
Change (% chg)

$-0.61 (-5.34%)
Prev Close
$11.43
Open
$11.22
Day's High
$12.17
Day's Low
$10.53
Volume
392,616
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.94

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

Earnings vs. Estimates